From AHA 2018, an analysis gives clue to how empagliflozin cuts cardiovascular risk , and study findings challenge cholesterol guidelines for patients with type 1 diabetes. Also, we take a closer look at how smoke-free policies affect blood pressure , and how magazine-ranked "Best Hospitals" actually perform ....
The MDedge Cardiology team is back this week for part II of their conversation on the 2018 annual scientific session of the American Heart Association.
In this episode of the Cardiocast, the MDedge Cardiology team of reporters breaks down the 2018 annual scientific session of the American Heart Association.
This week on Cardiocast, guidelines for bradycardia set a new bar for shared decision-making in pacemaker placement, young adults with hypertension may be at higher CVD risk, how sleep quality affects cardiovascular risk, and a strong showing for exercise in patients with both heart failure and sleep apnea. Tune in next Friday for the most exciting news from the scientific sessions of the American Heart Association, as told by the reporters who cover it....
Today, an analysis that may challenge ASCVD guidelines , a new formula may predict adverse events from NSAIDs, a potentially important myocardial infarction risk factor is identified, and a diabetes drug gets a new cardiovascular indication....
Why wire-dependent fractional flow reserve may soon be obsolete ; stroke risk after a myocardial infarction goes on three times longer than previously thought; poststroke dual-antiplatelet therapy should be cut short ; and emergency departments are seeing results from greater use of high-sensitivity troponin T in chest pain patients....
This week, a revelation that coronary artery bypass grafting instead of percutaneous is safer as time goes by, a new index stretches the prognostic power of cardiac CT, a weight-loss drug cuts new-onset diabetes , and a controversial diet score is validated....
Angiography shouldn't end with a diagnosis of nonobstructive CAD, NSAIDs show cardiovascular and renal safety in the short term , a registry analysis supports use of direct oral anticoagulants over warfarin, and IVUS-guided stent placement bests angiography-led placement....
This week, the dangers of yo-yoing metabolic factors, adding an antiplatelet to oral anticoagulation does no good in atrial fib patients who’ve undergone stenting, how pill burden affects the ability to reach systolic BP control, and expert advice on how to get on top of home BP monitoring ....
This week, a breakthrough for heart failure patients with mitral regurgitation emerges, prosthesis-patient mismatch raises the risk of death following TAVR, a new study challenges anticoagulation guidelines , and a possible blessing in disguise for rivaroxaban comes from the massive COMPASS trial. Subscribe to Cardiocast wherever you get your podcasts. Amazon Alexa Apple Podcasts...
The MDedge cardiology team is back for the second edition of their debrief on the 2018 annual congress of the European Society of Cardiology. The team includes MDedge editor Catherine Hackett and MDedge reporters Bruce Jancin and Mitchel Zoler.
Radiation from coronary CT angiography plummeted in the past decade. Also this week, hospital stays for endocarditis patients are cut in half with a new protocol, children born from assisted reproductive technologies may be prone to cardiovascular problems , and elderly patients only benefit from statins if they have diabetes....
A new definition in myocardial infarction. Also today, aspirin and fish oil flap in patients with diabetes, CT angiography cuts MI in patients with stable chest pain, and rivaroxaban is no help for heart failure outcomes.
The MDedge Cardiology team unpacks one of the world’s largest cardiology meetings from a Munich beer garden. Join MDedge reporters Bruce Jancin and Mitchel Zoler alongside MDedge Cardiology editor Catherine Hacket as they discuss practice-changing data as well as what the world’s leading cardiologists are talking about. Some of the stories discussed in this episode are: ASCEND: Aspirin, fish oil flop in diabetes Rivaroxaban no help for heart failure outcomes Rivaroxaban superior to aspirin for e...
New data from an observational study show that breastfeeding was linked with a lower risk of stroke later in life. Also today, a new Valsalva maneuver is tops at converting supraventricular tachycardia to sinus rhythm, and a warning about the growing occurrence of finding about a key component of some artificial hearts
Breast artery calcification, evident on every mammogram, may help refine coronary artery disease risk in women. Also this week, new guidelines reclassify adult congenital heart disease, advice to eat a variety of foods seems to have backfired, and how PCI can now safely tackle complex chronic total occlusions.
Cardiologists in states with payment limits for medical malpractice claims practice less defensive medicine. Also this week, Herceptin is linked to doubling heart failure risk in women with breast cancer, Sapien 3 performs mostly well in bicuspid aortic stenosis, and PhRMA leads the way in healthcare lobbying.
Female authorship in cardiology journals has increased over the last 20 years. However, it still lags behind other specialties and academic medicine overall. Also this week, valsartan recall and risk , synergy DES shines in acute MI, and incident heart failure is linked to HIV infection....
Hypertension meds slashed mild cognitive impairment risk by 19% in the SPRINT MIND study. Are omega-3 fatty acids' heart benefits just another fish tale? Early antidepressant therapy after a heart attack delivers benefits years later. And new guidelines say PFO closure is the best way to prevent recurrent stroke.
The “devil’s bargain” of epinephrine use in cardiac arrest plays out in a new analysis. Also this week, updated recommendations reflect maturation of transcatheter aortic valve replacement, a comparison of cardiovascular protection in type 2 diabetes drugs, and sweeping reductions in documentation requirements headline a new Medicare fee schedule proposal.
The safety of direct oral anticoagulants is affirmed in a real-world study; a wearable ECG boosts atrial fibrillation detection by a factor of 8; new pediatric guidelines catch more hypertension cases in children; and nontraditional cardiovascular risk factors are not ready for prime time, says a federal task force. Listen to MDedge Cardiocast for all the details on the week’s top news, and subscribe on iTunes.
A reanalysis of the ATLAS ACS 2-TIMI 51 trial shows rivaroxaban in a different light; cerebral protection may be appropriate in all TAVR procedures, regardless of anatomy; The Feds' big stick vs. carrot approach worked in cutting inappropriate ICD use: and canagliflozin's perported amputation risk didn't make a showing in a real-word study.
Left atrial appendage closure slashes stroke risk in high-risk atrial fibrillation patients with Amplatzer Amulet; how diabetes patients fared with alirocumab in ODYSSEY Outcomes; the new word in stents is "abluminal"; and cheerful news about midlife fitness. Listen to Cardiocast for the week's top news.
A controversial study on abdominal aortic aneurysm screening, the importance of healthy lifestyle in diabetes, how NIH scientists corrupted a big alcohol study, and cardiologists' chart-topping starting salaries.
Low anticoagulant adherence in atrial fib cost DOAC users more than warfarin users in thromboembolic events. The USPSTF says additional ECGs in asymptomatic, low-risk adults don’t do any good. Can C-reactive protein apheresis reduce post-MI infarct size?
Transcatheter aortic valves delivered better hemodynamic valve performance and less structural valve deterioration than surgical valves over 6 years. Transcatheter aortic valves outlast surgical valves in the NOTION study presented at EuroPCR. From Heart Rhythm 2018, a registry study suggests myocarditis is the culprit in many cases of frequent premature ventricular contractions , and one set of Botox shots into intracardiac fat pads cut atrial fibrillation for up to 3 years. Also this week, man...
Welcome to the MDedge Cardiocast, the new weekly podcast from Cardiology News. We start with news from Paris, where EuroPCR saw noninvasive diagnostic methods defy accepted practice in patients with triple-vessel and stable coronary artery disease, as well as a resurrection of renal denervation for hypertension....
